Navigation Links
Prof. Dr. George Gettinby Honored With Dieter Lutticken Award
Date:5/19/2008

therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its website is http://www.schering-plough.com.

For more information about Intervet/Schering-Plough Animal Health visit the following website: http://www.intervet.com http://www.spah.com


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ready: UH prof. chronicles phenomenon of new later motherhood
2. AlphaMed Press Names George Kendall Vice President, Operations and Business Development
3. Georgetown researchers find stem cell marker controls 2 key cancer pathways
4. George Institute receives Gates Foundation grant to survey funding flows
5. Georgetown U student selected for prestigious Bouchet Society
6. Home Oxygen Community Applauds Senator George Voinovich for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
7. American Tailgaters Association, ESPNs Sean Salisbury and George Foreman Unite in the Fight Against Pediatric Cancers Around Super Bowl XLII
8. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
9. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
10. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)... The Accreditation Council for Continuing Medical ...on of the College of American Pathologists (CAP) t...provider of continuing medical education for physi...PRWEB) August 28, 2008 -- The Accreditation Counci...rded the Education Division of the www.cap.org [...
(Date:8/28/2008)... Leading personal injury law firm files notice of ...olice Department. , Mineo...esandersfirm.com/attorney.asp?attorneyid=14 [Marc...sonal injury law firm of Sanders, Sanders, Block, ...York, today announced that his firm has filed a No...
(Date:8/27/2008)...g. 27 /PRNewswire-FirstCall/ -- Replidyne, Inc.,(N...f its operations reducing,its current employee hea...ons that are scheduled to take place during Septem...tions Replidyne will suspend further,development a...r the,treatment of Clostridium difficile (C. diffi...
(Date:8/27/2008)...revention experts have long known that teens are l... while driving. Now, researchers from the Meharry-...e discovered lack of seat belt use by teen passeng...t ever direct comparison of the differences betwee...lly representative teen population, the Meharry re...
Breaking Medicine News(10 mins):Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Replidyne Announces Restructuring of Operations 2Health News:Teens making poor choices when it comes to riding in vehicles 2
...rogative of choice. They seem to be partial to mid...gy Neurosurgery and Psychiatry suggests that // Fa...ptions to middle aged women with headache as compa...normally spur the patients to a doctor and account...
...Newcastle's Royal Victoria Infirmary was accused o...d from Denton Burn, Newcastle. // She was struck o...gainst her were all proved. A hearing at the Nursi...he said that she was too ill to attend the hearing...
...ve formulated a combination of drugs that could wa...long time that new borns did not feel any pain. //...nt research. The problem was how to stop this pain...n of infants. Principal investigator Anna Taddio...
...me the rage of dance lovers in discos has been fou.../ Ecstasy was first synthesised in 1910. It was p...k Pharmaceuticals as an appetite suppressant. The...loud music exacerbates the effects of ecstasy on t...
Other Medicine News:Health News:The effects of Ecstasy more pronounced in presence of music 2
(Date:8/25/2008)...racle, LATHAM, N.Y., Aug. 25 /PRNewswire-FirstCa...Therapy program at Community Care Physicians in,La... RapidArc(TM),radiotherapy technology from Varian ... delivers a highly-precise image-guided,intensity...nutes or less., RapidArc treatments spare healthy...
(Date:8/22/2008)...-, - Dangerous Bacteria Infect Three Million Peop...-tried can also be innovative: already in,Ancient ...bial. This,ability is now playing an important rol.... In a worldwide noted field test, a whole hospita...urg, Germany, was equipped with,door handles, door...
(Date:8/21/2008)...swire/ -- Dangerous disease,often spreads faster t...that, researchers at Kansas State University have ... to hours., Sanjeev Narayanan, assistant professo...h in the department of diagnostic medicine and,pat...array to seek out the,specific genetic markers tha...
(Date:8/21/2008)...cated pain relief plaster,(Versatis) is now appro...,restricted use within NHS Scotland for patients s...ottishmedicines.org.uk/smc/5850.html . This,revers...y 2007) for,Versatis (5% lidocaine medicated plast...effectiveness comparative data and brings prescrib...
Breaking Medicine Technology:Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Shingles Pain Treatment Will Benefit More Patients 2Shingles Pain Treatment Will Benefit More Patients 3Shingles Pain Treatment Will Benefit More Patients 4Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 1Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 2Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 4Interferon does not slow or stop hepatitis C from worsening study finds 5962 1Interferon does not slow or stop hepatitis C from worsening study finds 5962 2UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 1UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 2Pill Poses Little Cervical Cancer Risk 5956 1Pill Poses Little Cervical Cancer Risk 5956 2Pill Poses Little Cervical Cancer Risk 5956 3
...Pancreatic Enzyme Replacement Therapy Significantl...inical Trials, MILAN, Italy and DAYTON, Ohio, Apri...lty pharmaceutical company, today unveiled,data fr...ct,candidate, Zentase(TM), formerly EUR-1008, for ... (EPI). The US Food and Drug,Administration (FDA) ...
... Presented at the XXI Congress of the Internationa... FRANCISCO, Calif., April 04, 2007 /PRNewswire/ --...t it has received,positive results from EXPERT, a ...T054021, for the prevention of venous,thromboembol...urgery. Based on these results, Portola will advan...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 2Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: